Efficacy of Trichloroacetic Acid in Patients with Alopecia Areata: A Clinico-Histopathological Study [PDF]
International Journal of Medical Arts, 2023 Background: Alopecia areata is an autoimmune disorder caused by a breakdown in the follicular immune privilege system, resulting in non-scarring hair loss. Many therapeutic options have been tested with variable results.
Hossam Anter +3 more
doaj +1 more source
Alopecia totalis: An unusual early manifestation of azathioprine myelosuppression
Indian Journal of Ophthalmology - Case ReportsR. Kene +3 more
semanticscholar +2 more sources
Emerging Topical and Systemic JAK Inhibitors in Dermatology [PDF]
, 2019 Accumulating data on cellular and molecular pathways help to develop novel therapeutic strategies in skin inflammation and autoimmunity. Examples are psoriasis and atopic dermatitis, two clinically and immunologically well-defined disorders.
Ghoreschi, Kamran +2 more
core +1 more source
Attenuation of Autoimmune Phenomena in a Patient with Autoimmune Polyglandular Syndrome Type 1
Case Reports in Endocrinology, 2021 Autoimmune polyglandular syndrome type 1 (APS1) is a progressive life-threatening illness with no known cure. Current treatments involve replacement of the hormone deficiencies that result from autoimmune destruction of multiple endocrine organs.
Jill D. Jacobson +3 more
doaj +1 more source
Establishing and Prioritising Research Questions for the Treatment of Alopecia Areata: The Alopecia Areata Priority Setting Partnership [PDF]
, 2017 BACKGROUND: Alopecia areata is a common hair loss disorder that results in patchy to complete hair loss. Many uncertainties exist around the most effective treatments for this condition. OBJECTIVES: To identify uncertainties in alopecia areata management
Brockley, J.R. +14 more
core +2 more sources
Siriraj Medical Journal, 2017 Background: Alopecia totalis (AT) and alopecia universalis (AU) have a high rate of recurrence and are very difficult to treat. To date, no consensus has been reach among clinicians regarding the best way to treat these conditions.
Rattapon Thuangtong
doaj +3 more sources
Modified platelet rich plasma therapy for alopecia totalis
Journal of Cutaneous and Aesthetic Surgery, 2023 Alopecia areata (AA) is an autoimmune disease characterized most commonly by patchy nonscarring hair loss which may progress to alopecia totalis which has poor prognosis. Platelet-rich plasma (PRP) therapy along with intralesional triamcinolone acetonide
Avita Dhiman, Manmohan Bagri
semanticscholar +1 more source
Retrospective review of diphencyprone in the treatment of alopecia areata [PDF]
, 2015 Contact immunotherapy with diphencyprone (DCP) is used to treat alopecia areata (AA). Its reported efficacy is variable, and individual response cannot be predicted.
Holmes, S., Lamb, R. C., Young, D.
core +1 more source
A RARE CASE OF VITAMIN D DEPENDENT RICKETS TYPE-2A PRESENTED AS ALOPECIA TOTALIS
PARIPEX-INDIAN JOURNAL OF RESEARCH, 2023 Rickets is a disease of growing bone caused by unmineralized matrix at the growth plates in children only before fusion of the epiphyses. Ÿ There are many causes of rickets, including vitamin D disorders, calcium deficiency, phosphorus deficiency, and ...
M. V.Sreevani yadav +3 more
semanticscholar +1 more source
Synchronous pancreas and gallbladder cancer with concomitant alopecia totalis.
Turkish Journal of Surgery, 2023 A 55-year-old female presented with history of pain in the right hypochondrium along with complete loss of facial and scalp hair over last two months. On evaluation, she was found to have locally advanced, synchronous malignancies of the gallbladder and ...
Saket Kumar, A. Chandra
semanticscholar +1 more source